Korro Bio

KRRONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$191.099 M

$13.25 +9.32%

Close of 7 Aug 2026

Revenue

$6.39M

#3258 by revenue

Earnings

-$117.3M

Loss-making

Shares outstanding

14,725,646

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#270ImmunicIMUX$194.8M
#271Tonix PharmaceuticalsTNXP$191.8M
#272Korro BioKRRO$191.1M
#273Lifecore Biomedical, Inc. DeLFCR$189.6M
#274Corbus PharmaceuticalsCRBP$188.4M

Where these numbers come from

Share counts and financials for Korro Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.